409 related articles for article (PubMed ID: 15855577)
1. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
[TBL] [Abstract][Full Text] [Related]
2. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
Banarer S; McGregor VP; Cryer PE
Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
[TBL] [Abstract][Full Text] [Related]
3. Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.
Israelian Z; Gosmanov NR; Szoke E; Schorr M; Bokhari S; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 Nov; 28(11):2691-6. PubMed ID: 16249541
[TBL] [Abstract][Full Text] [Related]
4. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans.
Raju B; Cryer PE
Diabetes; 2005 Mar; 54(3):757-64. PubMed ID: 15734853
[TBL] [Abstract][Full Text] [Related]
5. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
6. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
7. Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus.
Israelian Z; Szoke E; Woerle J; Bokhari S; Schorr M; Schwenke DC; Cryer PE; Gerich JE; Meyer C
Metabolism; 2006 May; 55(5):593-8. PubMed ID: 16631434
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.
Bolli G; De Feo P; Perriello G; De Cosmo S; Compagnucci P; Santeusanio F; Brunetti P; Unger RH
J Clin Invest; 1984 Apr; 73(4):917-22. PubMed ID: 6368593
[TBL] [Abstract][Full Text] [Related]
9. Catecholamines in prevention of hypoglycemia during exercise in humans.
Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
Degn KB; Brock B; Juhl CB; Djurhuus CB; Grubert J; Kim D; Han J; Taylor K; Fineman M; Schmitz O
Diabetes; 2004 Sep; 53(9):2397-403. PubMed ID: 15331551
[TBL] [Abstract][Full Text] [Related]
11. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
12. Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy males.
Norjavaara E; Ericsson H; Sjöberg F; Leonsson-Zachrisson M; Sjöstrand M; Morrow LA; Hompesch M
J Clin Endocrinol Metab; 2012 Sep; 97(9):3319-25. PubMed ID: 22723318
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
Gabriely I; Wozniak R; Hawkins M; Shamoon H
J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
[TBL] [Abstract][Full Text] [Related]
14. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
[TBL] [Abstract][Full Text] [Related]
16. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
[TBL] [Abstract][Full Text] [Related]
17. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
[TBL] [Abstract][Full Text] [Related]
18. Basal insulin, glucagon, and growth hormone replacement.
Breckenridge SM; Raju B; Arbelaez AM; Patterson BW; Cooperberg BA; Cryer PE
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1303-10. PubMed ID: 17711984
[TBL] [Abstract][Full Text] [Related]
19. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
20. The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans.
Peacey SR; Rostami-Hodjegan A; George E; Tucker GT; Heller SR
J Clin Endocrinol Metab; 1997 May; 82(5):1458-61. PubMed ID: 9141533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]